Fundz

Alithia Genomics secures $3.2m in seed funding led by TechU Ventures and Novalis Biotech to scale up RNA sequencing product manufacturing.

PRIVATEMar 15, 2024

Amount Raised

$3.2 Million

Round Type

Seed

LausanneManufacturingBiotechnologyHealth Care

Investors

Novalis BiotechTech U Ventures

Description

Alithia Genomics, a Switzerland-based startup, has raised SFrF2.8m ($3.2m) in seed funding to expand its manufacturing capacity for RNA sequencing products and establish a US subsidiary. The funding round was led by new investor TechU Ventures and existing investor Novalis Biotech.

Quick answer

Alithea Genomics raised $3.2 Million in a Seed round, dated March 15, 2024. Investors: Novalis Biotech and Tech U Ventures. Alithea Genomics is based in Lausanne, Vaud, Switzerland.

How much did Alithea Genomics raise?
Alithea Genomics raised $3.2 Million in a Seed round on March 15, 2024.
Who invested in Alithea Genomics?
Novalis Biotech and Tech U Ventures are named as investors in this round.
What does Alithea Genomics do?
Alithea Genomics is a Switzerland-based startup specializing in manufacturing ribonucleic acid (RNA) sequencing products to study gene expressions of cells, with a focus on cancer research.
Where is Alithea Genomics based and how big is it?
Alithea Genomics is based in Lausanne, Vaud, Switzerland.
Who are the decision-makers at Alithea Genomics?
Fundz holds 1 contact at Alithea Genomics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Alithea Genomics that raised within 45 days of this round, from Fundz verified event records.

  • Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.
  • Harvard Apparatus Regenerative Technology raised $1.5M on April 15, 2024.
  • OsseoLabs raised $2M (Series A) on April 15, 2024.
  • 22nd Century raised $4.2M (Seed) on April 8, 2024.
  • Neurovalens raised $2.7M (Seed) on April 8, 2024.
  • ViaLase raised $38M on March 25, 2024.

Who to call at Alithea Genomics, and when

A new round usually means Alithea Genomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alithea Genomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alithea Genomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alithea Genomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alithea Genomics

Location

Lausanne, Vaud, Switzerland

About

Alithea Genomics is a Switzerland-based startup specializing in manufacturing ribonucleic acid (RNA) sequencing products to study gene expressions of cells, with a focus on cancer research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alithea Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alithea Genomics's next move

See what Strategic adds

Alithea Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.